 Fuyong Xing
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microscopy | 10 | 2023 | 147 | 2.900 |
Why?
| | Neuroendocrine Tumors | 8 | 2024 | 119 | 2.450 |
Why?
| | Image Interpretation, Computer-Assisted | 9 | 2019 | 288 | 1.910 |
Why?
| | Algorithms | 22 | 2023 | 1845 | 1.340 |
Why?
| | Image Processing, Computer-Assisted | 11 | 2024 | 779 | 1.310 |
Why?
| | Cell Nucleus | 4 | 2019 | 588 | 1.280 |
Why?
| | Ki-67 Antigen | 2 | 2020 | 117 | 1.180 |
Why?
| | Histological Techniques | 3 | 2023 | 39 | 0.950 |
Why?
| | Data Curation | 1 | 2024 | 21 | 0.810 |
Why?
| | Diagnosis, Computer-Assisted | 5 | 2017 | 92 | 0.790 |
Why?
| | Supervised Machine Learning | 2 | 2021 | 23 | 0.750 |
Why?
| | Organometallic Compounds | 1 | 2023 | 113 | 0.740 |
Why?
| | Pattern Recognition, Automated | 5 | 2017 | 74 | 0.710 |
Why?
| | Machine Learning | 9 | 2026 | 587 | 0.630 |
Why?
| | Pancreatic Neoplasms | 4 | 2019 | 928 | 0.610 |
Why?
| | Learning | 1 | 2023 | 443 | 0.580 |
Why?
| | Immunohistochemistry | 2 | 2020 | 1716 | 0.550 |
Why?
| | Cell Shape | 2 | 2016 | 56 | 0.520 |
Why?
| | Lung Neoplasms | 9 | 2020 | 2664 | 0.510 |
Why?
| | Sensitivity and Specificity | 12 | 2017 | 1997 | 0.460 |
Why?
| | Reproducibility of Results | 14 | 2023 | 3413 | 0.410 |
Why?
| | Models, Anatomic | 1 | 2013 | 87 | 0.360 |
Why?
| | Positron-Emission Tomography | 2 | 2024 | 343 | 0.350 |
Why?
| | Tomography, X-Ray Computed | 4 | 2025 | 2769 | 0.320 |
Why?
| | Biopsy | 1 | 2013 | 1082 | 0.290 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 1189 | 0.250 |
Why?
| | Cell Tracking | 2 | 2017 | 18 | 0.250 |
Why?
| | Muscle, Skeletal | 1 | 2016 | 1789 | 0.240 |
Why?
| | Humans | 31 | 2026 | 145475 | 0.230 |
Why?
| | Biomarkers, Tumor | 1 | 2013 | 1321 | 0.230 |
Why?
| | Intracranial Pressure | 1 | 2026 | 65 | 0.220 |
Why?
| | Lupus Nephritis | 1 | 2025 | 67 | 0.220 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 108 | 0.220 |
Why?
| | Staining and Labeling | 2 | 2023 | 153 | 0.210 |
Why?
| | Skull | 1 | 2025 | 162 | 0.210 |
Why?
| | Gallium Radioisotopes | 1 | 2023 | 16 | 0.200 |
Why?
| | Radionuclide Imaging | 1 | 2023 | 115 | 0.200 |
Why?
| | Brain Neoplasms | 3 | 2016 | 1329 | 0.180 |
Why?
| | Decision Support Systems, Clinical | 1 | 2026 | 272 | 0.170 |
Why?
| | Precision Medicine | 1 | 2025 | 459 | 0.160 |
Why?
| | Databases, Factual | 4 | 2020 | 1490 | 0.160 |
Why?
| | Image Enhancement | 4 | 2017 | 200 | 0.160 |
Why?
| | Breast Neoplasms | 4 | 2019 | 2382 | 0.160 |
Why?
| | Datasets as Topic | 2 | 2019 | 118 | 0.160 |
Why?
| | Brain | 3 | 2019 | 2947 | 0.160 |
Why?
| | Histocytochemistry | 2 | 2017 | 78 | 0.160 |
Why?
| | Brain Injuries, Traumatic | 1 | 2026 | 453 | 0.150 |
Why?
| | Cytological Techniques | 2 | 2017 | 27 | 0.150 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 122 | 0.150 |
Why?
| | Connectome | 1 | 2019 | 93 | 0.130 |
Why?
| | Pathology, Clinical | 1 | 2017 | 29 | 0.130 |
Why?
| | Myositis | 1 | 2017 | 57 | 0.120 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 919 | 0.110 |
Why?
| | Efficiency | 1 | 2015 | 103 | 0.110 |
Why?
| | Breast | 1 | 2015 | 156 | 0.110 |
Why?
| | Cell Separation | 1 | 2015 | 305 | 0.110 |
Why?
| | Pathology | 1 | 2014 | 21 | 0.110 |
Why?
| | Pancreas | 1 | 2016 | 341 | 0.100 |
Why?
| | Atrial Fibrillation | 1 | 2020 | 558 | 0.100 |
Why?
| | Information Storage and Retrieval | 1 | 2014 | 123 | 0.100 |
Why?
| | Computer Simulation | 2 | 2019 | 1003 | 0.090 |
Why?
| | Systems Integration | 1 | 2013 | 36 | 0.090 |
Why?
| | Cell Size | 1 | 2013 | 92 | 0.090 |
Why?
| | Cell Polarity | 1 | 2013 | 137 | 0.090 |
Why?
| | Microarray Analysis | 1 | 2011 | 116 | 0.090 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 337 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2020 | 1196 | 0.090 |
Why?
| | Risk Assessment | 1 | 2020 | 3747 | 0.080 |
Why?
| | Female | 10 | 2026 | 78845 | 0.070 |
Why?
| | Artificial Intelligence | 1 | 2013 | 381 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2019 | 3904 | 0.070 |
Why?
| | Infant | 3 | 2026 | 10077 | 0.060 |
Why?
| | Nephrocalcinosis | 1 | 2025 | 12 | 0.060 |
Why?
| | Child, Preschool | 3 | 2026 | 11853 | 0.060 |
Why?
| | Models, Biological | 1 | 2013 | 1764 | 0.060 |
Why?
| | Regression Analysis | 2 | 2019 | 1001 | 0.050 |
Why?
| | Glasgow Coma Scale | 1 | 2026 | 218 | 0.050 |
Why?
| | Monitoring, Physiologic | 1 | 2026 | 288 | 0.050 |
Why?
| | Signal-To-Noise Ratio | 1 | 2023 | 73 | 0.050 |
Why?
| | Artifacts | 1 | 2023 | 143 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2025 | 6447 | 0.050 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2023 | 143 | 0.050 |
Why?
| | Child | 3 | 2026 | 22707 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 2 | 2015 | 641 | 0.040 |
Why?
| | Male | 6 | 2026 | 72843 | 0.040 |
Why?
| | Autoimmunity | 1 | 2025 | 933 | 0.040 |
Why?
| | Functional Neuroimaging | 1 | 2019 | 59 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2020 | 166 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2019 | 428 | 0.030 |
Why?
| | Adenocarcinoma | 2 | 2015 | 925 | 0.030 |
Why?
| | Kidney | 1 | 2025 | 1497 | 0.030 |
Why?
| | Computer Graphics | 1 | 2017 | 41 | 0.030 |
Why?
| | Models, Neurological | 1 | 2019 | 250 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 321 | 0.030 |
Why?
| | Adolescent | 2 | 2026 | 22530 | 0.030 |
Why?
| | Brain Mapping | 1 | 2019 | 538 | 0.030 |
Why?
| | Nerve Net | 1 | 2019 | 284 | 0.030 |
Why?
| | Lung | 2 | 2020 | 4106 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2017 | 212 | 0.030 |
Why?
| | Cell Count | 1 | 2015 | 319 | 0.030 |
Why?
| | Politics | 1 | 2015 | 92 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2134 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2014 | 138 | 0.030 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2017 | 268 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5905 | 0.020 |
Why?
| | Feedback | 1 | 2014 | 180 | 0.020 |
Why?
| | High-Throughput Screening Assays | 1 | 2015 | 176 | 0.020 |
Why?
| | Color | 1 | 2013 | 81 | 0.020 |
Why?
| | Prospective Studies | 1 | 2026 | 8057 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2013 | 500 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2015 | 1508 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1374 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2011 | 251 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3155 | 0.020 |
Why?
| | Models, Statistical | 1 | 2014 | 671 | 0.020 |
Why?
| | Middle Aged | 2 | 2020 | 36215 | 0.020 |
Why?
| | Adult | 2 | 2020 | 40777 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 14219 | 0.010 |
Why?
| | Aged | 1 | 2020 | 26153 | 0.010 |
Why?
|
|
Xing's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|